Clinical Trial Update: Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial [Phase 2]

View source ↗

Summary

A Phase 2 CINTO trial is evaluating the combination of infliximab and tofacitinib for acute severe ulcerative colitis; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Acute Severe Ulcerative Colitis | Phase 2 | Status: NOT_YET_RECRUITING